1. |
Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med, 2004, 350(24): 2487-2498.
|
2. |
Inoue N, Fushimi K. Adjunctive corticosteroids decreased the risk of mortality of non-HIV Pneumocystis pneumonia. Int J Infect Dis, 2019, 79: 109-115.
|
3. |
Ding L, Huang H, Wang H, et al. Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies. Ann Intensive Care, 2020, 10(1): 34.
|
4. |
Fujikura Y, Manabe T, Kawana A, et al. Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in non-HIV-infected patients: a systematic review and meta-analysis of observational studies. Arch Bronconeumol, 2017, 53(2): 55-61.
|
5. |
Fishman JA. Pneumocystis jiroveci. Semin Respir Crit Care Med, 2020, 41(1): 141-157.
|
6. |
Fishman JA, Gans H. Pneumocystis jiroveci in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant, 2019, 33(9): e13587.
|
7. |
Pareja JG, Garland R, Koziel H. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest, 1998, 113(5): 1215-1224.
|
8. |
Bollée G, Sarfati C, Thiéry G, et al. Clinical picture of Pneumocystis jiroveci pneumonia in cancer patients. Chest, 2007, 132(4): 1305-1310.
|
9. |
Hosseini-Moghaddam SM, Shokoohi M, Singh G, et al. A multicenter case-control study of the effect of acute rejection and cytomegalovirus infection on pneumocystis pneumonia in solid organ transplant recipients. Clin Infect Dis, 2019, 68(8): 1320-1326.
|
10. |
Wieruszewski PM, Barreto JN, Frazee E, et al. Early corticosteroids for Pneumocystis pneumonia in adults without HIV are not associated with better outcome. Chest, 2018, 154(3): 636-644.
|
11. |
Monnet X, Vidal-Petiot E, Osman D, et al. Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection. Crit Care, 2008, 12(1): R28.
|
12. |
Schmidt JJ, Lueck C, Ziesing S, et al. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care, 2018, 22(1): 307.
|